Pele Therapeutics
PrivateLast Round
Accelerator
Aug 28, 2024
Company Overview
Pele Therapeutics is a biotechnology company that operates an in vivo protein therapy platform intended to treat metabolic and fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pele Therapeutics Comparables
Compare Pele Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sixfold Bioscience | 77% | |
| Anjarium Biosciences | 76% | |
| Sail Biomedicines | 76% |
Pele Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 28, 2024 |
Pele Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Activation Capital | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 28, 2024
Received funding from Activation Capital.
Pele Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pele Therapeutics's valuation, stock price, and market status.
Is Pele Therapeutics a public or private company?
Pele Therapeutics is a private company.
What is the current stock price of Pele Therapeutics?
Pele Therapeutics is a private company with no public stock price. Caplight tracks Pele Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Pele Therapeutics worth (valuation)?
Valuation information for Pele Therapeutics is not publicly available.
Can I buy Pele Therapeutics stock?
Pele Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pele Therapeutics's last funding round?
Pele Therapeutics's most recent funding round was Accelerator on August 28, 2024.
Who are the main investors in Pele Therapeutics?
Key investors in Pele Therapeutics include Activation Capital.
Will Pele Therapeutics IPO soon?
No public IPO plans have been announced for Pele Therapeutics.
How can I track Pele Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pele Therapeutics's secondary market activity and sign up for updates.